Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_assertion type Assertion NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_head.
- NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_assertion description "[These results provide a conceptual framework for the combined deployment of BRAF(V600E) plus PI3K pathway-targeted inhibitors in the treatment of a subset of patients with BRAF-mutated melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_provenance.
- NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_assertion evidence source_evidence_literature NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_provenance.
- NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_assertion SIO_000772 25472943 NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_provenance.
- NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_assertion wasDerivedFrom befree-2016 NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_provenance.
- NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_assertion wasGeneratedBy ECO_0000203 NP1244661.RAZhBwsqXYd0-6p0dnaeU1pArVDn21MJ9IVzV8j2a77Nw130_provenance.